ClarityStorm — Reconciled, versioned snapshot of the FDA adverse-event (FAERS) quarterly extracts: the four 2023 quarterly releases merged into one internally consistent cohort — keeping the maximum observed case version per case, applying the deletion lists those releases supplied, and purging child rows belonging to superseded reports — delivered as seven relational tables (case demographics plus drug, indication, therapy, reaction, outcome and death tables) with documented join semantics. Small, precise, single-analyst scale: a 1.5M-case reconciled cohort with published schemas and honest,…
ClarityStorm — Reconciled, versioned snapshot of the FDA adverse-event (FAERS) quarterly extracts: the four 2023 quarterly releases merged into one internally consistent cohort — keeping the maximum observed case version per case, applying the deletion lists those releases supplied, and purging child rows belonging to superseded reports — delivered as seven relational tables (case demographics plus drug, indication, therapy, reaction, outcome and death tables) with documented join semantics. Small, precise, single-analyst scale: a 1.5M-case reconciled cohort with published schemas and honest,…
ClarityStorm offers (Alternative, Reference) — 1,541,888 case rows across seven related tables, including roughly 6.38M rows on the drug table; reconciliation removed 2,819,928 child rows belonging to superseded reports and the applied deletion lists excluded 3,103 previously retained cases; 623 repeated drug groups (636 additional rows) deliberately preserved.
Clean-base analysis of a single-year adverse-event cohort without hand-reconciling four quarterly files and their deletion lists (the join-multiplication and version-duplication traps the listing documents are precisely what silently corrupt naive analyses); pharmacovigilance teaching and validation datasets; benchmarking an in-house FAERS pipeline against a known-reconciled reference; model training and regression testing where a frozen, reproducible snapshot is required instead of a moving live feed; audit trail for a published analysis that must be rerun against identical bytes
Coverage spans US, UK; Pharmaceuticals, Application Software; alternative, reference; equities.
Not yet on file: Summary & mission · Use cases & buyers · FAQ